Significant Ownership of First Light Asset Management, LLC
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for First Light Asset Management, LLC focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Kurt T. Peterson - Kurt T. Peterson/Chief Compliance Officer
- Manager location
- Edina, MN
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow First Light Asset Management, LLC with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from First Light Asset Management, LLC
Significant Ownership of First Light Asset Management, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SIBN | SI-BONE, Inc. | Common Stock, $0.001 par value | 18% | $107,278,225 | +$38,975,022 | 8,120,986 | +57% | Mathew P. Arens | 30 Apr 2026 |
| HCAT | Health Catalyst, Inc. | Common Stock, $0.01 par value | 18% | $26,796,092 | -$909,928 | 13,465,373 | -3.3% | Mathew P. Arens | 12 Mar 2026 |
| MASS | 908 Devices Inc. | Common Stock, $0.001 par value | 17% | $33,397,591 | +$8,120,952 | 6,184,739 | +32% | Mathew P. Arens | 31 Dec 2025 |
| PHLT | Performant Healthcare, Inc. | Common Stock, $0.01 par value | 16% | $53,117,291 | 12,923,915 | Mathew P. Arens | 30 Jun 2025 | ||
| SLP | Simulations Plus, Inc. | Common Stock, $0.001 par value | 13% | $48,307,294 | 2,649,879 | First Light Asset Management, LLC | 31 Jan 2026 | ||
| NEO | Neogenomics, Inc. | Common Stock, $0.01 par value | 11% | $115,847,880 | +$35,417,243 | 14,093,416 | +44% | Mathew P. Arens | 30 Apr 2026 |
| TLSI | TriSalus Life Sciences, Inc. | Common Stock, $0.01 par value | 11% | $24,010,321 | +$4,448,535 | 6,596,242 | +23% | First Light Asset Management, LLC | 30 Jun 2026 |
| NPCE | NeuroPace, Inc. | Common Stock, $0.01 par value | 8.7% | $38,863,812 | 2,955,423 | Mathew P. Arens | 31 Mar 2026 | ||
| KRMD | KORU Medical Systems, Inc. | Common Stock, $0.01 par value | 8.3% | $21,417,945 | -$5,550,194 | 3,831,475 | -21% | Mathew P. Arens | 31 Dec 2025 |
| PVLA | PALVELLA THERAPEUTICS, INC. | Common Stock, $0.01 par value | 7.5% | $89,137,745 | 887,031 | First Light Asset Management, LLC | 31 Dec 2025 | ||
| AXGN | Axogen, Inc. | Common Stock, $0.01 par value | 6.8% | $119,861,458 | -$76,951,680 | 3,617,913 | -39% | Mathew P. Arens | 30 Apr 2026 |
| ANAB | AnaptysBio Inc. | Common Stock, $0.01 par value | 3.1% | $26,474,603 | -$42,907,347 | 864,618 | -62% | Mathew P. Arens | 30 Sep 2025 |
| ORGO | Organogenesis Holdings Inc. | Common Stock, $0.01 par value | 3.1% | $16,371,915 | -$18,610,675 | 3,888,816 | -53% | Mathew P. Arens | 31 Dec 2025 |
| FNA | Paragon 28, Inc. | Common Stock, $0.01 par value | 1.7% | $18,718,661 | -$119,897,999 | 1,429,997 | -86% | Mathew P. Arens | 28 Feb 2025 |
| OPRX | OptimizeRx Corporation | Common Stock, $0.01 par value | 0% | $0 | 0 | First Light Asset Management, LLC | 31 Dec 2024 |
Schedules 13D/G Reported by First Light Asset Management, LLC:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.